Trinseo (NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, will showcase its plastics and highlight its recent ISO 13485 achievement at MD&M West 2017 in Anaheim, California. The company will exhibit at Booth 538 in Hall E for the duration of the show, which runs from February 7- 9, 2017.
Trinseo has supported the medical device industry for almost three decades. The company is focused on providing high quality custom polycarbonate, ABS and polystyrene compounds consistently and reliably. Its recent ISO 13485:2016 certification furthers this commitment and addresses the imperatives of quality, risk management and speed to market that are so important to medical device customers.
Trinseo’s focus at MD&M West is on its MAGNUM™ ABS Resins and EMERGE™ Advanced Resins for applications including drug delivery devices (e.g., inhalers, insulin pens, nebulizers, etc.) as well as equipment housings. The company’s ABS offers the advantage of mass polymerization technology resulting in lower residual monomers, exceptional purity, brilliant whiteness, and lot-to-lot consistency.
The Company’s other flagship products to be featured at the show include CALIBRE™ Polycarbonate Resins and CALIBRE™ MEGARAD™ Polycarbonate resins, Trinseo’s color-stabilized grades for applications needing to be sterilized. The company also will highlight its biocompatible ISO 10993-compliant glass-filled resins with varying percentages of glass content for applications needing structural strength.
To arrange a meeting with Trinseo onsite at MD&M West 2017 contact Paula Biskup, global business communications manager.
Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, appliances, consumer electronics, medical devices, electrical, building and construction, textile, paper and board, footwear and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.